「outcomes」の検索結果

Set up authorized C2 simulation workflows and measure defensive detection outcomes.

日本語の概要は準備中です。原文の説明を表示しています。

Builds and improves task-specific decision artifacts from application requirements and labeled records. Use for data assembly, primitive and base-model selection, fitting, export/reload, inference policy, or bounded data/model/program improvement. Includes rules and no-training outcomes; does not require a rung ladder or training a general Jev.

日本語の概要は準備中です。原文の説明を表示しています。

Route agent work through AccInt's MCP memory loop: retrieve prior outcomes, resolve frames, and close commitments with evidence.

日本語の概要は準備中です。原文の説明を表示しています。

Use when evaluating a completed or in-progress project across scope, correctness, quality, testing, and learning outcomes using structured Praise-Critique-Grow feedback.

日本語の概要は準備中です。原文の説明を表示しています。

Builds and maintains a DRAFT impact log from notes, messages, status updates and completed work: one row per outcome with its evidence and evidence level, date, who benefited and the source it traces to, plus a gap list of outcomes that still lack evidence, structured so a later review, appraisal or promotion case can draw on it. Use when the user asks to "start an impact log", "add this to my impact log", "log what I achieved this quarter", "pull my wins out of these notes", "turn these messages into evidence for my review" or "what do I have evidence for so far". Do not use for a performance rating, ranking, pay or promotion decision, the skill records evidence and never judges it; for the review narrative itself, use performance-review-drafter; for a role profile built from the work, use job-description-drafter instead. Drafts for human review; never approves, authorises or signs off.

日本語の概要は準備中です。原文の説明を表示しています。

Produces a DRAFT 30-60-90 day onboarding plan for a new hire from the role, the team context and the systems list: phase outcomes traced to the role, activities with a named owner and due window, an access and equipment request table, learning items, manager checkpoints and the items the manager must confirm. Use when the user asks to "build an onboarding plan for our new hire", "draft the induction plan for this role", "write a first 90 days plan", "put together a new starter plan with owners", "create a ramp plan from this job description" or "plan the integration of an internal mover". Do not use for writing the job description itself, use job-description-drafter instead; for interview questions or a scorecard, use interview-scorecard-builder. Drafts for human review; never approves, authorises or signs off.

日本語の概要は準備中です。原文の説明を表示しています。

Reconstruct a daily or weekly worklog from observed activity and outcomes.

日本語の概要は準備中です。原文の説明を表示しています。

Research any open-source repository end to end and answer the core question — SHOULD YOU contribute to it? — with a GO / NO-GO / GO-IF verdict backed by evidence: snapshot, momentum, contribution landscape (PR acceptance rates, outside-contributor merge rates, first-timer outcomes), issue health, governance, community sentiment, and a final go/no-go recommendation. Use when the user asks 'should I contribute to X', wants a before-I-contribute due-diligence check on a project, asks whether a project accepts outside PRs, wants contribution-health numbers like PR merge rates or stale-PR counts, or asks for a deep dive on an open-source codebase's health and dynamics before investing time in it.

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks to "audit our launch plan", "are we ready to launch", or evaluate launch execution/outcomes; runs one typed RAMP preflight, execution, or outcome profile without mixing time horizons. Not for recording launch state — use launch-registry; not for running launch day — use launch-day-conductor. 发布就绪审计/RAMP分阶段评估/发布前放行

日本語の概要は準備中です。原文の説明を表示しています。

Use when the user asks to "log this launch", query a launch date/embargo, record a stage transition, or update submissions/outcomes; curates launch facts through the append-only launches event stream with optimistic revisions and derived dossier/calendar views. Not for RAMP scoring — use launch-readiness-auditor; not for planning tier/window — use launch-tier-planner. 发布台账/发布日历/阶段与禁运期记录

日本語の概要は準備中です。原文の説明を表示しています。

Use when summarizing agent evaluations where autonomous, assisted, failed, timed-out, or invalid outcomes must remain distinct and comparable.

日本語の概要は準備中です。原文の説明を表示しています。

Performs logistic regression for clinical trial outcomes (binary, ordinal, multinomial) with marginal-vs-conditional estimand reporting per FDA 2023 covariate adjustment guidance, g-computation/standardisation for marginal effects, modified Poisson for RR, Brant test for proportional odds, Firth penalty for separation, and Hauck-Donner detection. Use when modeling binary or ordinal endpoints in confirmatory or exploratory clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Tests associations between categorical variables in clinical data using chi-square, Fisher's exact, Boschloo, Cochran-Mantel-Haenszel, and modern McNemar variants with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen). Use when analyzing categorical outcomes, paired binary endpoints, or testing treatment-outcome independence in confirmatory or exploratory clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Builds diagnostic and prognostic classifiers on omics feature matrices with regularized logistic regression, random forest, and gradient-boosted trees, handling the p>>n regime, batch shortcut learning, class imbalance, and probability calibration. Use when building a classifier from expression, methylation, or variant data, choosing an algorithm for high-dimensional small-n data, or diagnosing a suspiciously perfect AUC. For unbiased evaluation see machine-learning/model-validation; for feature selection see machine-learning/biomarker-discovery; for time-to-event outcomes see machine-learning/survival-analysis.

日本語の概要は準備中です。原文の説明を表示しています。

Lay out how a job search will actually run alongside a current job: the hours available each week and what they go to, how weekday daytime slots for interviews will be found, which routes to use (direct applications, job boards, scout sites, agents, referrals, public employment services) and what each one discloses to whom, how to keep the search from reaching the current employer through public profiles or workplace equipment, a single tracker of every application's stage, next action, and deadline, and a date and conditions for reviewing, reducing, or pausing the search. Use when someone has decided to start looking, or to gather information while employed, and asks how to fit it in, which routes to use, whether the applications they are running fit the time they have, or how to keep track of them; do not use to decide whether to change jobs, to pick or rate employers or job postings, to predict outcomes, or to send applications, publish profiles, or contact agents on the user's behalf.

日本語の概要は準備中です。原文の説明を表示しています。

Help a user talk through whether to change jobs, stay, or change something in their current work, starting from uncertainty, distress, a vague sense of stagnation, an offer in hand, a counter-offer from the current employer, or pressure from family or colleagues. Clarify what matters, separate deadlines that order the next steps from the decision itself, compare conditional options, and agree on a small next step and a time to revisit it. Use when someone asks whether they should quit, wonders whether leaving is just running away, has second thoughts after receiving an offer or being asked to stay, feels stuck because others say it would be a waste, wants to leave soon after joining, or wants advice before deciding to start a job search; do not make the final stay-or-leave decision, evaluate offer terms, plan the resignation, or predict hiring outcomes.

日本語の概要は準備中です。原文の説明を表示しています。

Prepare for a Japanese job interview by working from the documents already submitted: find where an interviewer will dig in (claims the applicant cannot back up, work described in the first person plural, outcomes with no measure, gaps or overlaps in the employment history, must-have requirements the documents never answer), and turn them into questions to prepare evidence for. Use when a user has an interview scheduled and wants to know what will be asked and what to have ready, or wants to prepare reverse questions from earlier company research; do not use to predict whether they will pass, to write answers containing experience they did not report, or to schedule or contact anyone.

日本語の概要は準備中です。原文の説明を表示しています。

Reply to an applicant for an employer's Otameshi Tenshoku listing: match the application against the listed requirements item by item on what the applicant actually stated, list the questions still open, and draft an invitation, a request for clarification, a hold notice or a decline that sticks to the listed conditions, keeps other applicants and internal notes out, and presents any new work or dates as a proposal rather than an agreed term. Use when a hiring manager, recruiter or small-business owner has applications to answer, wants to know what to ask before inviting, or has to decline; do not use to judge an applicant's aptitude or predict hiring outcomes, to screen on personal attributes unrelated to the work, to design the work (trial-work-design) or the listing (trial-listing-draft), or to send the message or update applicant records on the user's behalf.

日本語の概要は準備中です。原文の説明を表示しています。

Research a specific company before applying or interviewing by gathering facts from primary and official sources, recording the source and date behind every claim, and keeping anonymous or unverifiable material clearly separated from confirmed fact. Use when a user asks what a company actually does, how it makes money, what its published conditions are, whether a posting matches the company's own disclosures, or what to verify before an interview; do not use to predict hiring outcomes, to repeat review-site content as fact, or to bulk-crawl sites that prohibit automated access.

日本語の概要は準備中です。原文の説明を表示しています。

Quantifies CRISPR editing outcomes with CRISPResso2 (Clement 2019 Nat Biotechnol) across Cas9-nuclease (indels, HDR), CBE and ABE base editors (target conversion + bystander), and prime editor (pegRNA-templated) modes. Covers single-amplicon (CRISPResso), multi-sample batch (CRISPRessoBatch), pooled-amplicon (CRISPRessoPooled), WGS off-target (CRISPRessoWGS), and sample-comparison (CRISPRessoCompare) workflows; quantification-window math that controls what is called edited; substitution-vs-indel diagnostic to distinguish BE from Cas9 contamination; MMEJ deletion pattern interpretation; allele-frequency tables; and failure modes from amplicon misalignment or contamination. Use when quantifying editing from amplicon sequencing, choosing CRISPResso mode by design, distinguishing intended edits from bystanders and indel byproducts, debugging low-alignment runs, or generating publication-grade editing reports.

日本語の概要は準備中です。原文の説明を表示しています。

Performs logistic regression for clinical trial outcomes (binary, ordinal, multinomial) with marginal-vs-conditional estimand reporting per FDA 2023 covariate adjustment guidance, g-computation/standardisation for marginal effects, modified Poisson for RR, Brant test for proportional odds, Firth penalty for separation, and Hauck-Donner detection. Use when modeling binary or ordinal endpoints in confirmatory or exploratory clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Tests associations between categorical variables in clinical data using chi-square, Fisher's exact, Boschloo, Cochran-Mantel-Haenszel, and modern McNemar variants with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen). Use when analyzing categorical outcomes, paired binary endpoints, or testing treatment-outcome independence in confirmatory or exploratory clinical trials.

日本語の概要は準備中です。原文の説明を表示しています。

Predicts whether a DNA variant alters mRNA splicing using sequence-based deep-learning tools — SpliceAI (10kb context dilated CNN, clinical default), Pangolin (multi-tissue), MMSplice (modular per-region CNN with calibrated ΔPSI), SpliceTransformer/TrASPr (tissue-aware transformers), SpliceVault (empirical 300K-RNA lookup of likely mis-splicing outcomes), CADD-Splice (composite score). Applies the ClinGen SVI 2023 framework for ACMG/AMP variant interpretation (PVS1, PP3, BP4 evidence codes), HGVS splicing nomenclature (c.123+1G>A, c.123-3T>G, r.spl?), extended-window scoring for deep-intronic pseudoexons, tissue-specific predictions, branchpoint variant detection (BPHunter, LaBranchoR), and splice-switching ASO design. Use when interpreting splice impact of clinical variants, prioritizing VUS, identifying deep-intronic pathogenic variants, or designing ASOs.

日本語の概要は準備中です。原文の説明を表示しています。

Guides agents through scorecards, outcomes, model profiles, and eval suites. Use when running /cc-scorecard or /cc:scorecard, measuring a deliverable, or checking workflow gates with suite-run.

日本語の概要は準備中です。原文の説明を表示しています。